Lower plasma NAMPT/visfatin levels are associated with impaired hepatic mitochondrial function in non-diabetic obese women: A potential link between obesity and non-alcoholic fatty liver disease

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 2, 2012, Pages

  Ruiz, J R ^a   Lasa, A ^b   Simon, E ^c   Larrarte, E ^c   Labayen, I ^d  

^a UNIVERSITY OF GRANADA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d TECNALIA RESEARCH AND INNOVATION   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; BLOOD; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMAN; LETTER; LIVER; METABOLISM; MIDDLE AGED; MITOCHONDRION; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; CHOLESTEROL, HDL; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMANS; LIVER; MIDDLE AGED; MITOCHONDRIA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; TRIGLYCERIDES; YOUNG ADULT;

EID: 84856597199     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.03.003     Document Type: Letter

References (8)

1. Rector R.S., Thyfault J.P., Uptergrove G.M., Morris E.M., Naples S.P., Borengasser S.J., et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 2010, 52:727-736.
2. Grattagliano I., Lauterburg B.H., Palasciano G., Portincasa P. 13C-breath tests for clinical investigation of liver mitochondrial function. Eur J Clin Invest 2010, 40:843-850.
3. Arner P. Visfatin-a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab 2006, 91:28-30.
4. Parra D., Gonzalez A., Martinez J.A., Labayen I., Diez N. In vivo assessment of the mitochondrial response to caloric restriction in obese women by the 2-keto[1-C]isocaproate breath test. Metabolism 2003, 52:463-467.
5. Jarrar M.H., Baranova A., Collantes R., Ranard B., Stepanova M., Bennett C., et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008, 27:412-421.
6. Catalán V., Gómez-Ambrosi J., Rodríguez A., Ramírez B., Silva C., Rotellar F., et al. Association of increased Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity. Nutr Metab Cardiovasc Dis 2011 Apr, 21(4):245-253.
7. Dahl T.B., Haukeland J.W., Yndestad A., Ranheim T., Gladhaug I.P., Damås J.K., et al. Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2010, 95:3039-3047.
8. de Boer J.F., Bahr M.J., Boker K.H., Manns M.P., Tietge U.J. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis. Am J Physiol Gastrointest Liver Physiol 2009, 296:G196-G201.